comparemela.com

Latest Breaking News On - Immunoadoptive cell therapy private - Page 1 : comparemela.com

Laurus Labs further invests in gene therapy tech, increases its stake in lmmunoACT to 33.86%

ImmunoACT has portfolio of Chimeric Antigen Receptor T cells (CAR-T cells) therapy assets under various development stages for the treatment of multiple auto immune diseases and oncology indications.

United-states
Hyderabad
Andhra-pradesh
India
Mumbai
Maharashtra
American
Satyanarayana-chava
Neha-myneni
Rahul-purwar
Immunoadoptive-cell-therapy-private
Laurus-lab

vimarsana © 2020. All Rights Reserved.